Exhibit 4.12
WARRANT
THIS WARRANT AND THE SHARES ISSUABLE
HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE U.S. SECURITIES ACT OF
1933, AS AMENDED (THE “1933 ACT”), OR ANY STATE
SECURITIES LAWS. THIS WARRANT MAY NOT BE EXERCISED EXCEPT PURSUANT
TO AN AVAILABLE EXEMPTION FROM SUCH REGISTRATION
REQUIREMENTS.
THESE SECURITIES MAY NOT BE OFFERED,
SOLD, PLEDGED OR OTHERWISE TRANSFERRED EXCEPT (A) PURSUANT TO
AN EFFECTIVE REGISTRATION THEREOF UNDER THE 1933 ACT AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, (B) TO THE
COMPANY, (C) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH
REGULATION S UNDER THE 1933 ACT, (D) IN COMPLIANCE WITH THE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS UNDER THE 1933 ACT
PROVIDED BY RULE 144 OR RULE 144A THEREUNDER, IF AVAILABLE, AND IN
ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS, OR (E) IN A
TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE 1933 ACT
OR ANY APPLICABLE STATE LAWS.
|
Issuer
Corporations:
|
NeuroMed
Technologies Inc. (“ NeuroMed Canada ”), a
corporation incorporated under the Yukon Business Corporations
Act and
|
NeuroMed Pharmaceuticals Inc.
(“ NeuroMed US ”), a corporation incorporated
under the laws of Delaware
|
Number of Option
Securities
|
20,000
|
|
Option Securities:
|
At the election
of the Holder either of:
|
|
|
(a) at any time
prior to the Exchange Time, Units (“Units”) consisting
of:
|
|
|
(i)
one (1) Exchangeable Share of NeuroMed Canada;
and
|
|
|
(ii)
one (1) Special Voting Share of NeuroMed Canada;
and
|
|
|
(iii)
one (1) Common Special Voting Share of NeuroMed US;
|
|
|
(b) at any time
after the Exchange Time, one (1) Common Share of NeuroMed US
(an “Option Share”)
|
|
|
(each Unit or
Option Share being hereinafter referred to as an “ Option
Security ”)
|
|
Initial Exercise
Price:
|
U.S. $1.15 per
Option Security (the “Initial Exercise
Price”)
|
|
Issue Date:
|
October 22, 2004 (the “Issue
Date”)
|
|
Expiration Date:
|
4:30 p.m.
(Vancouver time), on the earlier of (the “Expiration
Date”) October 22, 2009 and one (1) year after an
initial public offering by a Company
|
THIS WARRANT CERTIFIES THAT, for
good and valuable consideration, the receipt of which is hereby
acknowledged, COMERICA BANK or its assignee (the “
Holder ”) is entitled to purchase the number of fully
paid and non-assessable Option Securities of NeuroMed Canada and
NeuroMed US, as the case may be (individually a “
Company ” and collectively, the “
Companies ”), subject to the provisions and upon the
terms and conditions set out this Warrant.
ARTICLE 1
EXERCISE
|
1.1
|
Grant . The
Companies hereby grant to the Holder the right to purchase in whole
or in part, at any time and from time to time prior to the
Expiration Date, the number of Option Securities set out above at
the Initial Exercise Price per Option Security as set forth above,
and as adjusted pursuant to the terms of this Warrant (the “
Warrant Price ”).
|
|
1.2
|
Method of
Exercise . The
Holder may, at any time and from time to time, until the Expiration
Date exercise this Warrant, in whole or in part, by delivering to
the office of either of the Companies set out in Section 4.5
of this Warrant:
|
|
|
(a)
|
a duly executed
Notice of Exercise in substantially the form attached as
Appendix 1;
|
|
|
(b)
|
if the Holder
is exercising this Warrant to acquire Units, a copy of the Exchange
Agreement duly executed by the Holder or a covenant to do so upon
being provided by NeuroMed Canada with a copy of the Exchange
Agreement; and
|
|
|
(c)
|
unless Holder
is exercising the cashless conversion right set out in
Section 1.3, a certified cheque or bank draft for the
aggregate subscription price for the Option Securities so
subscribed for.
|
|
1.3
|
Cashless
Conversion Right . In
lieu of exercising this Warrant in the manner specified in,
Section 1.2, the Holder may, by delivering to the office of
either of the Companies as set out in Section 4.5, a duly
executed Notice of Exercise in substantially the form attached as
Appendix 1, at any time and from time to time until the
Expiration Date, convert this Warrant, in whole or in part, into
that number of Option Securities determined by dividing
(a) the aggregate Fair Market Value of the Option Securities
in respect of which the Warrant is so being converted minus the
product of the Warrant Price and the number of cash Option
Securities in respect of which the Warrant is so being converted by
(b) the Fair Market Value of one Unit or one Common Share, as
the case may be, for which this Warrant is then being
exercised.
|
|
1.4
|
Repurchase on Acquisition
.
|
|
|
(a)
|
“
Acquisition .” For the purpose of this Warrant,
“ Acquisition ” means any transaction or series
of transactions resulting in:
|
|
|
(i)
|
the sale,
license, or other disposition of all or substantially all of the
assets (including intellectual property) or business of either of
the Companies; or
|
|
|
(ii)
|
any
reorganization, consolidation, amalgamation, arrangement, merger or
other business combination involving either of the Companies and
which results in holders of the voting securities of either such
Company outstanding before such transaction beneficially owning
less than 50% of the outstanding voting securities of the surviving
or successor entity after such transaction (other than as a result
of the exercise of the Exchange Rights or a mere re-incorporation
or corporate continuance); or
|
|
|
(iii)
|
a take-over
bid, tender offer, share exchange or other transaction whereby more
than 50% of the outstanding voting securities of either of the
Companies are acquired by any person or one or more persons acting
jointly or in concert (other than as a result of the exercise and
the Exchange Rights).
|
|
|
(b)
|
Assumption of
Warrant . The Companies
shall use their reasonable best efforts to cause the surviving or
successor entity or offeror under an Acquisition to assume in
writing the obligations of this Warrant such that upon the closing
or effective date of any Acquisition this Warrant will be
exercisable or convertible so as to allow the Holder to acquire on
exercise hereof the same securities, cash and property as would be
issuable or payable in consideration for the Option Securities
issuable upon
|
2
|
|
exercise of the unexercised portion
of this Warrant as if such Option Securities were outstanding on
the closing or effective date of such Acquisition.
|
|
|
(c)
|
Non-assumption . If upon the closing or effective date of any
Acquisition the surviving or successor entity or offeror has not
assumed in writing the obligations of this Warrant as contemplated
in Section 1.4(b) above, the Holder shall have the right
to:
|
|
|
(i)
|
deem this
Warrant to have been automatically converted pursuant to the
cashless conversion right in Section 1.3 hereof immediately
prior to the closing or effective date of such Acquisition such
that the Holder shall thereupon be entitled to participate in the
Acquisition on the same terms as other holders of the Option
Securities; or
|
|
|
(ii)
|
require either
of the Companies to purchase this Warrant, for cash, payable as
soon as practicable upon the closing or effective date of such
Acquisition for an amount per Option Security equal to two
(2) times the Warrant Price in effect at such time.
|
|
1.5
|
Delivery
of Certificate and New Warrant . Upon
exercise or conversion of this Warrant in the manner contemplated
herein, the person or persons in whose name or names; the Option
Securities issuable upon exercise of the Warrant are to be issued
shall be deemed for all purposes to be the holder or holders of
record such Option Securities and promptly upon the Holder
exercising or converting this Warrant, the Companies shall deliver
or cause to be delivered to Holder certificates for the Option
Securities acquired and, if this Warrant has not been fully
exercised or converted and has not expired, a new Warrant
representing the balance of the Warrant not then exercised or
converted.
|
|
1.6
|
Exchange
of Warrants . At
the option of the Holder, this Warrant may be surrendered to and
exchanged at the registered office of either of the Companies for
one or more Warrant of a like tenor and aggregate number of Option
Securities to which the exchanged Warrant is entitled.
|
|
1.7
|
Replacement of Lost or Mutilated
Warrant . On
receipt of evidence reasonably satisfactory to either of the
Companies of the loss, theft, destruction or mutilation of this
Warrant and, in the case of loss, theft or destruction, on delivery
of an indemnity agreement reasonably satisfactory in form and
amount to the Companies or, in the case of mutilation, on surrender
and cancellation of this Warrant, the Companies at its expense
shall execute and deliver, in lieu of this Warrant, a new Warrant
of like tenor, and the Holder shall be entitled to the same rights
and benefits of the Warrant so lost, stolen or
mutilated.
|
|
1.8
|
Exercise
Restrictions . This
Warrant may not be exercised unless an exemption from the
registration requirements of the 1933 Act and all applicable state
securities laws is available and the Holder has delivered to the
Companies an opinion of counsel reasonably satisfactory to the
Companies to such effect; provided, however, that the original
purchaser of this Warrant, and any affiliate of the original
purchaser to whom it assigns this Warrant, shall not be required to
deliver an opinion of counsel in connection with its exercise of
this Warrant if it confirms that the representations and warranties
set forth in Section 3.5 of this Warrant remain true and
correct.
|
ARTICLE 2
EVENTS OF
ADJUSTMENTS
|
2.1
|
Reclassification, Exchange
or Substitution . If
at any time prior to the Expiration Date either of the Companies
(a) declares or pays a dividend or makes any other
distribution of additional securities on any of the Underlying
Securities or other securities convertible into or exchangeable or
exercisable for Underlying Securities, (b) subdivides or
redivides its outstanding Underlying Securities into a greater
number of shares, or (c) consolidates or combines its
outstanding Underlying Securities into a lesser number of shares or
there is any reclassification, recapitalization, substitution,
capital reorganization or other event resulting in a
|
3
|
|
change in the Underlying Securities,
then in any such event, the Holder shall be entitled to receive,
upon exercise or conversion of this Warrant, the number and kind of
securities or other property that the Holder would have received
for the Underlying Securities if this Warrant had been exercised
immediately before such reclassification, recapitalization,
substitution, capital reorganization or other event. If necessary
as a result of such event, adjustments shall be made as nearly
equivalent as may be practicable to the adjustments provided for in
this Article 2 including, without limitation, adjustments to
the Warrant Price and to the number of Underlying Securities,
securities or property issuable upon exercise of the
Warrant.
|
|
2.2
|
Special
Distributions . If
at any time prior to the Expiration Date either of the Companies
makes a distribution to all or substantially all of the holders of
any of the Underlying Securities of (i) shares of any class,
other than securities, whether of either of the Companies or any
other company, (ii) rights, options or warrants (other than
rights, options or warrants exercisable by the holders thereof
within a period expiring not more than 30 days after the date of
issue thereof), (iii) evidences of indebtedness, or
(iv) cash securities or other property or assets, then, in
each such case this Warrant shall represent the right to receive,
upon exercise or conversion of this Warrant, the number and kind of
securities or other property that the Holder would have received
for the Underlying Securities if this Warrant had been exercised
immediately before such distribution. If necessary as a result of
such event, adjustments shall be made as nearly equivalent as may
be practicable to the adjustments provided for in this
Article 2 including, without limitation, adjustments to the
Warrant Price and to the number of Underlying Securities,
securities or property issuable upon exercise of the
Warrant.
|
|
2.3
|
Other
Adjustments . The
Board of Directors of the respective Company shall, in good faith,
make any such other appropriate or equitable adjustment to the
Warrant Price or securities or property issuable upon the exercise
or conversion thereof as may be necessary or desirable in respect
of any transaction or event not expressly provided for in this
Article 2.
|
|
2.4
|
Adjustments Successive
. The adjustments provided for in this Article are
cumulative, shall, in the case of any adjustment to the Exercise
Price, be computed to the nearest one-tenth of one cent, and in the
case of any adjustment to the number of Underlying Securities
purchasable upon exercise or conversion of this Warrant, be
computed to the nearest one one-hundredth of one share of such
Underlying Security, as the case may be, and will apply (without
duplication) to successive subdivisions, consolidations,
distributions, issuances or other events resulting in any
adjustment under the provisions hereof.
|
|
2.5
|
Fractional Shares . Notwithstanding Section 2.4, no fractions
of Underlying Securities shall be issuable upon exercise or
conversion of this Warrant and the number of Underlying Securities
to be issued shall be rounded down to the nearest whole Share. If a
fractional share interest arises upon any exercise or conversion of
this Warrant, the Companies shall, in lieu of such fractional
interest, pay the Holder an amount computed by multiplying the
fractional interest by the Fair Market Value of such Underlying
Security.
|
|
2.6
|
No
Impairment . Neither of the Companies shall, by amendment of
their respective Articles of Incorporation or other constating
document or through a reorganization, transfer of assets,
consolidation, merger, dissolution, issue, or sale of securities or
any other voluntary action, avoid or seek to avoid or frustrate the
observance or performance of any of the terms to be observed or
performed under this Warrant, but shall at all times in good faith
assist in carrying out all the provisions of this Article 2
and in taking all such action or making such adjustments as may be
necessary, appropriate or equitable in the circumstances, acting
reasonably, in order to protect the Holder’s rights under
this Article against impairment.
|
|
2.7
|
Certificate as to
Adjustments . Whenever there shall occur an event giving rise
to an adjustment under this Article 2, the Companies at their
expense shall promptly compute such adjustment and furnish the
Holder with a certificate signed by their respective Chief
Financial Officer setting forth the adjustment and the facts upon
which such adjustment is based. The Companies shall, upon written
request, furnish the Holder with a
|
4
|
|
certificate setting out the Warrant
Price and Shares or other securities or other property issuable
upon the exercise of this Warrant in effect upon the date thereof
and adjustments leading thereto.
|
ARTICLE 3
REPRESENTATIONS AND
COVENANTS
|
3.1
|
Representations and Warranties of the
Company . The
Companies hereby jointly and severally represent and warrant to the
Holder as follows:
|
|
|
(a)
|
any Underlying
Securities which may be issued upon the exercise or conversion of
this Warrant, and all securities, if any, issuable upon conversion
or exchange of such Underlying Securities, shall, upon issuance, be
duly authorized, validly issued, fully paid and non-assessable, and
free of any liens and encumbrances except for restrictions on
transfer provided for herein or under applicable Canadian
provincial or US federal and state securities laws;
|
|
|
(b)
|
the
capitalization table fo
|
|